Abstract:Patent ductus arteriosus (PDA) is a common congenital heart disease that develops soon after birth when the arterial duct does not remodel. Mutations in TFAP2B , which encodes a neural crest-derived transcription factor, can cause Char syndrome, characterized by PDA, facial dysmorphism, and skeletal abnormalities of the hand. The TFAP2B mutations result in a great amount of phenotypic variability, and a novel TFAP2B mutation has been found in patients with nonsyndromic PDA. Therefore, this study investigated whether TFAP2B mutations can cause familial nonsyndromic PDA. Clinical data and peripheral blood specimens were collected from two kindreds (A and B) and from a cohort of 100 unrelated subjects with PDA. Kindred A spanned three generations, in which 5 of the 16 individuals had PDA, and kindred B spanned three generations, in which 2 of the 13 individuals had PDA. The study enrolled 100 unrelated healthy individuals as control subjects. Polymerase chain reaction (PCR) was used to amplify seven exons and flanking introns of the TFAP2B gene. A few exons of the TFAP2B gene were amplified using reverse transcription polymerase chain reaction (RT-PCR), and direct forward and reverse sequencing of the PCR products was performed. The acquired sequences were aligned with those in GenBank by using a basic local alignment search tool (BLAST). The following two types of mutations were identified in TFAP2B : c.601+5G>A and c.435_438delCCGG. The mutation c.601+5G>A was detected in the affected members of kindred A. Nested PCR showed a splice junction in intron 3 and a 61-bp deletion in exon 3. The mutation c.435_438delCCGG, found in the affected members of kindred B, was caused by a four-base deletion in exon 2, which in turn caused a frame shift that resulted in the formation of a premature stop codon, p.Arg145Argfsx45. None of these mutations was detected in the unaffected members of the kindred or in the control group. Furthermore, two novel single-nucleotide polymorphisms (SNPs), c.1-34G>A and c.539+62G>C, were detected in the introns. The variant c.1-34G>A was identified 34 bp upstream of the transcription initiation site in the TFAP2B gene. Significant differences in the prevalence of the alleles G and A were observed in the control subjects and PDA patients ( Z = −2.513, P = 0.012). The study identified that another variant was c.539+62G>C but that the frequency of this variant was similar between the control subjects and the PDA patients ( Z = −0.332, P = 0.74). The TFAP2B mutations may be associated with isolated nonsyndromic, hereditary PDA in Chinese families. The authors propose that a TFAP2B mutation should be considered a risk factor for isolated PDA. However, the detailed genetic mechanism underlying nonsyndromic the PDA-causing TFAP2B mutation is yet to be elucidated.

[Mutation of TFAP-2B Gene in Patients with Patent Ductus Arteriosus].

Familial Nonsyndromic Patent Ductus Arteriosus Caused by Mutations in TFAP2B

Single Nucleotide Polymorphisms of TFAP-2B Gene in Children with Patent Ductus Arteriosus

Exon 47 Skipping of Fibrillin-1 Leads Preferentially to Cardiovascular Defects in Patients with Thoracic Aortic Aneurysms and Dissections

Characterization of transcription factor AP-2 beta mutations involved in familial isolated patent ductus arteriosus suggests haploinsufficiency

Tfap2b Mutation in Mice Results in Patent Ductus Arteriosus and Renal Malformation.

Patent Ductus Arteriosus and Pulmonary Valve Stenosis in a Patient with 18p Deletion Syndrome.

Identification and Functional Verification of CITED2 Gene Promoter Region in Patients with Patent Ductus Arteriosus.

[Novel GATA4 Mutations Identified in Patients with Congenital Atrial Septal Defects].

Next Generation Sequencing Identify Rare Copy Number Variants in Non-syndromic Patent Ductus Arteriosus

[Mutation of NKX2-5 Gene in Patients with Atrial Septal Defect].

A Novel Gata4 Mutation Responsible for Congenital Ventricular Septal Defects

Investigation of a new NR2F2 mutation responsible for congenital heart defect

PITX2c Loss-of-function Mutations Responsible for Congenital Atrial Septal Defects.

Rare Variants in Novel Candidate Genes Associated with Nonsyndromic Patent Ductus Arteriosus Identified with Whole-Exome Sequencing.

Novel PITX2c Loss-of-function Mutations Associated with Complex Congenital Heart Disease.

Identification of Two Mutations in PCDHGA4 and SLFN14 Genes in an Atrial Septal Defect Family.

A novel mutation in GATA4 gene associated with dominant inherited familial atrial septal defect.

A Harmful MYH11 Variant Detected in a Family with Thoracic Aortic Dissection and Patent Ductus Arteriosus.

[Metalloproteinase Tolloid-like 1 Gene Mutation in Chinese Patients with Sporadic Congenital Heart Diseases].

PTPN11 Gene Mutations and Its Association with the Risk of Congenital Heart Disease